CO5630028A2 - Compuestos cristalinos de n-formil hidroxilamina - Google Patents
Compuestos cristalinos de n-formil hidroxilaminaInfo
- Publication number
- CO5630028A2 CO5630028A2 CO05100510A CO05100510A CO5630028A2 CO 5630028 A2 CO5630028 A2 CO 5630028A2 CO 05100510 A CO05100510 A CO 05100510A CO 05100510 A CO05100510 A CO 05100510A CO 5630028 A2 CO5630028 A2 CO 5630028A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- carbon atoms
- aryl
- formil
- hydroxylamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
1.- Una sal cristalina de la fórmula (I): en donde:M es un metal mono- o di-valente;A es ½ o 1;cada uno de R2, R3, R4 y R5, independientemente, es hidrógeno o un grupo alifático, o (R2 o R3) y (R4 o R5), colectivamente forman un cicloalquilo de 4 a 7 átomos de carbono:A es uno de la fórmula (la), (lb), (lc), (Id) o (le):en donde:R12 es la cadena lateral de un alfa-aminoácido natural o no natural;R13 y R14, independientemente, representan hidrógeno o alquilo de 1 a 8 átomos de carbono opcionalmente substituido, cicloalquilo, arilo, aril(alquilo de 1 a 6 átomos de carbono), e heterocíclico o heterocíclico(alquilo de 1 a 6 átomos de carbono);R15 es hidrógeno, alquilo de 1 a 6 átomos de carbono o un grupo acilo;X es -CH2-, -S-, -CH(OH)-, -CH(OR)-, -CH(SH)-, -CH(SR)-, -CF2-, -C=N(OR)-, o -CH(F)-, en donde R es alquilo;R1 es arilo o heteroarilo; y n es 0-3, siempre que cuando n sea 0, X es -CH2-.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45972603P | 2003-04-02 | 2003-04-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5630028A2 true CO5630028A2 (es) | 2006-04-28 |
Family
ID=33131903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO05100510A CO5630028A2 (es) | 2003-04-02 | 2005-10-04 | Compuestos cristalinos de n-formil hidroxilamina |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20070135353A1 (es) |
| EP (1) | EP1613305A1 (es) |
| JP (1) | JP2006522054A (es) |
| KR (1) | KR20060002915A (es) |
| CN (1) | CN1764450A (es) |
| AR (1) | AR043804A1 (es) |
| AU (1) | AU2004226815B2 (es) |
| BR (1) | BRPI0409009A (es) |
| CA (1) | CA2520682A1 (es) |
| CL (1) | CL2004000705A1 (es) |
| CO (1) | CO5630028A2 (es) |
| EC (1) | ECSP056043A (es) |
| IS (1) | IS8093A (es) |
| MA (1) | MA27763A1 (es) |
| MX (1) | MXPA05010610A (es) |
| MY (1) | MY136854A (es) |
| NO (1) | NO20055097L (es) |
| NZ (1) | NZ542432A (es) |
| PE (1) | PE20050392A1 (es) |
| RU (1) | RU2005133660A (es) |
| SG (1) | SG166681A1 (es) |
| TN (1) | TNSN05248A1 (es) |
| TW (1) | TW200427458A (es) |
| WO (1) | WO2004087133A1 (es) |
| ZA (1) | ZA200507179B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2446931A1 (en) | 2001-06-15 | 2002-12-27 | Vicuron Pharmaceuticals Inc. | Pyrrolidine bicyclic compounds |
| PT1542968E (pt) | 2002-09-19 | 2009-03-25 | Novartis Ag | Processo para preparar intermediários |
| JP2006519786A (ja) | 2003-02-21 | 2006-08-31 | ノバルティス アクチエンゲゼルシャフト | Ｎ−ホルミルヒドロキシルアミン化合物を得るための中間体作成に関する化学的方法 |
| GT200600196A (es) * | 2005-05-23 | 2007-01-15 | Compuestos n-formil de hidroxilamina | |
| ES2930814T3 (es) * | 2016-05-11 | 2022-12-22 | Guangdong Hebo Pharmaceutical Co Ltd | Inhibidor de péptido deformilasa de anillo espiro de tres miembros o anillo espiro de cinco miembros y uso del mismo como agente antitumoral |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3282986A (en) * | 1960-10-06 | 1966-11-01 | Merck & Co Inc | N-acylated hydroxamic acids and derivatives thereof |
| US6423690B1 (en) * | 1998-02-07 | 2002-07-23 | British Biotech Pharmaceuticals Ltd. | Antibacterial agents |
| AR036053A1 (es) * | 2001-06-15 | 2004-08-04 | Versicor Inc | Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas |
-
2004
- 2004-03-29 TW TW093108548A patent/TW200427458A/zh unknown
- 2004-03-31 AR ARP040101079A patent/AR043804A1/es not_active Application Discontinuation
- 2004-03-31 PE PE2004000339A patent/PE20050392A1/es not_active Application Discontinuation
- 2004-04-01 KR KR1020057018676A patent/KR20060002915A/ko not_active Application Discontinuation
- 2004-04-01 BR BRPI0409009-8A patent/BRPI0409009A/pt not_active IP Right Cessation
- 2004-04-01 SG SG200801365-8A patent/SG166681A1/en unknown
- 2004-04-01 CN CNA2004800078725A patent/CN1764450A/zh active Pending
- 2004-04-01 US US10/550,631 patent/US20070135353A1/en not_active Abandoned
- 2004-04-01 WO PCT/EP2004/003478 patent/WO2004087133A1/en active IP Right Grant
- 2004-04-01 NZ NZ542432A patent/NZ542432A/en unknown
- 2004-04-01 CL CL200400705A patent/CL2004000705A1/es unknown
- 2004-04-01 AU AU2004226815A patent/AU2004226815B2/en not_active Ceased
- 2004-04-01 MY MYPI20041200A patent/MY136854A/en unknown
- 2004-04-01 EP EP04725014A patent/EP1613305A1/en not_active Ceased
- 2004-04-01 MX MXPA05010610A patent/MXPA05010610A/es unknown
- 2004-04-01 JP JP2006504952A patent/JP2006522054A/ja active Pending
- 2004-04-01 RU RU2005133660/04A patent/RU2005133660A/ru not_active Application Discontinuation
- 2004-04-01 CA CA002520682A patent/CA2520682A1/en not_active Abandoned
-
2005
- 2005-09-07 ZA ZA200507179A patent/ZA200507179B/en unknown
- 2005-09-28 EC EC2005006043A patent/ECSP056043A/es unknown
- 2005-09-30 TN TNP2005000248A patent/TNSN05248A1/en unknown
- 2005-10-04 CO CO05100510A patent/CO5630028A2/es not_active Application Discontinuation
- 2005-10-11 MA MA28547A patent/MA27763A1/fr unknown
- 2005-10-27 IS IS8093A patent/IS8093A/is unknown
- 2005-11-01 NO NO20055097A patent/NO20055097L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20060002915A (ko) | 2006-01-09 |
| AR043804A1 (es) | 2005-08-10 |
| MXPA05010610A (es) | 2005-11-23 |
| NO20055097D0 (no) | 2005-11-01 |
| PE20050392A1 (es) | 2005-06-19 |
| CA2520682A1 (en) | 2004-10-14 |
| MA27763A1 (fr) | 2006-02-01 |
| AU2004226815B2 (en) | 2007-07-19 |
| WO2004087133A1 (en) | 2004-10-14 |
| SG166681A1 (en) | 2010-12-29 |
| ECSP056043A (es) | 2006-01-27 |
| NZ542432A (en) | 2009-04-30 |
| TW200427458A (en) | 2004-12-16 |
| NO20055097L (no) | 2005-12-22 |
| IS8093A (is) | 2005-10-27 |
| EP1613305A1 (en) | 2006-01-11 |
| BRPI0409009A (pt) | 2006-03-28 |
| RU2005133660A (ru) | 2006-06-10 |
| MY136854A (en) | 2008-11-28 |
| CN1764450A (zh) | 2006-04-26 |
| ZA200507179B (en) | 2006-04-26 |
| TNSN05248A1 (en) | 2007-06-11 |
| CL2004000705A1 (es) | 2005-01-14 |
| JP2006522054A (ja) | 2006-09-28 |
| US20070135353A1 (en) | 2007-06-14 |
| AU2004226815A1 (en) | 2004-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5611131A2 (es) | Derivados de 5-feniltiazol y su uso como inhibidores de pi3 cinasa | |
| CO5630028A2 (es) | Compuestos cristalinos de n-formil hidroxilamina | |
| AR049291A1 (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso | |
| NO20090856L (no) | STAT3/5 activeringsinhibitor | |
| BR112012020986A2 (pt) | composto de amina cíclica e acaricida | |
| EA200970172A1 (ru) | Пролекарство соединения амида коричной кислоты | |
| DK114783D0 (da) | Hidtil ukendte forbindelser, fremgangsmader til deres fremstilling samt deres anvendelse som laegemidler | |
| DE3881489D1 (de) | Peptide mit collagenase hemmender wirkung. | |
| RU2018119775A (ru) | Композиции с улучшенным ингибирующим уреазу действием, содержащие триамид (тио)фосфорной кислоты и другие соединения | |
| NO20072198L (no) | Korrosjons- og gasshydratinhibitorer med foroket biologisk nedbrytbarhet og redusert toksisitet | |
| BR0313871A (pt) | Derivados aromáticos contendo nitrogênio | |
| RU2008139192A (ru) | N-формилгидроксиламины | |
| TR200400185T4 (tr) | PDE 5 inhibitörleri olarak, 8-kuinolinkisantin ve 8-izokuinolinkisantin türevleri. | |
| BR0114986A (pt) | Composto, composição farmacêutica, uso de pelo menos um composto ou um sal, solvato ou hidrato deste farmaceuticamente aceitáveis, e, processo para preparar triazolona partir de uma acil semicarbazida. | |
| MX2011010647A (es) | Analogos de isoxasol-3 (2h)-ona como agentes terapeuticos. | |
| BRPI1013482B8 (pt) | método para produzir um composto | |
| NO20073787L (no) | Nye pyrimidin-nukleosidforbindelser eller dets salt | |
| RS53379B (en) | N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES AND THE PROCEDURE FOR THEIR PREPARATION | |
| ES2545810T3 (es) | Proceso para estabilizar el contenido bacteriano de preparaciones mineral acuosas que comprendan carbonato cálcico natural molido y/o carbonato cálcico precipitado y/o dolomita y/o carbonato cálcico reaccionado en superficie | |
| EA200870191A1 (ru) | Новые производные циклической мочевины, их получение и фармацевтическое применение в качестве ингибиторов киназ | |
| WO2009109991A3 (en) | Novel hydrazide containing tyrosine kinase inhibitors | |
| BR112012033680A2 (pt) | solução aquosa capaz de absorver e coletar dióxido de carbono em gás de exaustão com eficiência alta | |
| TW200612931A (en) | Substituted biphenyl derivatives | |
| RU2013151880A (ru) | Крупномолекулярные гидрофобные поверхностно-активные вещества | |
| MY148980A (en) | Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |